NuVasive Announces Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
NuVasive (NUVA) PT Lowered to $75 at Truist Securities
November 10, 2021 6:48 AM ESTTruist Securities analyst Samuel Brodovsky lowered the price target on NuVasive (NASDAQ: NUVA) to $75.00 (from $80.00) while maintaining a Buy rating.
The analyst commented, "NUVA reported 3Q results with sales of $271M down ~8% sequentially, while adj. EPS came in at $0.32. Updated... More
NuVasive (NUVA) PT Lowered to $64 at Needham & Company
November 10, 2021 6:25 AM ESTNeedham & Company analyst Mike Matson lowered the price target on NuVasive (NASDAQ: NUVA) to $64.00 (from $73.00) while maintaining a Buy rating.
The analyst commented, "NUVA's 3Q21 revenue was in line with its preannouncement while its EPS missed consensus. Management lowered 2021 revenue guidance... More
NuVasive (NUVA) Misses Q3 EPS by 23c; Lowers Outlook
November 9, 2021 4:28 PM ESTNuVasive (NASDAQ: NUVA) reported Q3 EPS of $0.32, $0.23 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $270.8 million versus the consensus estimate of $293.18 million.
GUIDANCE:
NuVasive sees FY2021 EPS of $1.73-$1.83, versus the consensus of $2.23. NuVasive sees... More
